|

Allogeneic umbilical cord mesenchymal stem cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Ever Supreme Bio Technology Co., Ltd.2

Indications

  • ST Elevation Myocardial Infarction1
  • Heart Disease1
  • Multiple Sclerosis1

Other2 trials

Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
Phase 2
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.